Cadastre-se e crie alertas para ativos, eventos econômicos como também artigos de colaboradores
Cadastre-se grátis Já possui uma conta? Login
26,24
+0,04
+0,15%
Cotações
Todos os tipos de ativos
- Todos os tipos de ativos
- Índices
- Ações
- ETFs
- Fundos
- Commodities
- Moedas
- Cripto
- Título
- Certificados
Por favor, tente outra busca
⚖ Qual é o perfil de risco das ações dos meus favoritos? (Sim, você pode perguntar.)
WarrenAI te fala
Virtus Kar Health Sciences Fund Class A (RAGHX)
Adicionar/Remover de uma Carteira
Adicionar à carteira
05/06 - Dados em Atraso. Moeda em USD
- Classificação da Morningstar:
- Total de ativos: 97,8M
AllianzGI Health Sciences A
26,24
+0,04
+0,15%
RAGHX - Visão Geral
Nesta página, você encontrará um perfil aprofundado de Virtus Kar Health Sciences Fund Class A. Saiba mais sobre informações de gestão, ativos totais, estratégia de investimento e dados de contato de RAGHX, entre outras informações.
Informações de Contato
Endereço
Greenfield, MA, 01301
Greenfield,MA 01301
United States
Greenfield,MA 01301
United States
Telefone
+1 8002431574
Site
www.virtus.com
Principais Executivos
| Nome | Título | Desde | Até |
|---|---|---|---|
| Jon K Christensen | Portfolio Manager | 2022 | Agora |
| Biografia | Jon K. Christensen, CFA is a Portfolio Manager and a Senior Research Analyst with primary research responsibilities for the small and mid-capitalization health-care and industrials sector. He began his equity research career in 1995. Before joining Kayne Anderson Rudnick in 2001, Mr. Christensen was a Portfolio Manager and Senior Research Analyst for Doheny Asset Management. He earned a B.S. in Mathematics/Applied Science from the University of California, Los Angeles, and an MBA from the California State University, Long Beach. Mr. Christensen is a CFA charterholder. | ||
| Chris Armbruster | Portfolio Manager + Senior Research Analyst | 2022 | Agora |
| Biografia | Chris Armbruster, CFA is a Portfolio Manager & Senior Research Analyst with primary research responsibilities for the mid and large-capitalization communications services, consumer discretionary, health-care, and information technology sectors. He began his equity research career in 2005. Before joining Kayne Anderson Rudnick in 2013, Mr. Armbruster worked at B. Riley & Co. as an Associate Analyst covering Special Situations and at Al Frank Asset Management as a Vice President in Equity Research. Mr. Armbruster earned a B.A. in Business Economics, with a minor in Accounting, from the University of California, Los Angeles. Mr. Armbruster is a CFA charterholder and is a member of the CFA Society of Los Angeles, Inc. | ||
| Christopher Chin | - | 2020 | 2022 |
| Peter Pirsch | Senior Portfolio Manager | 2018 | 2022 |
| Biografia | Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 20 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder. | ||
| Bret Jones | Portfolio Manager | 2018 | 2019 |
| Biografia | Mr. Jones is a portfolio manager, senior analyst and a director with Allianz Global Investors, which he joined in 2018. He is a member of the Health Care team covering health care services companies.He was previously a senior health care analyst at Pura Vida Investments; Oppenheimer; Brean Murray, Carret and Leerink Swann. Before that, Mr. Jones was an equity research associate at SG Cowen. He has a B.S., magna cum laude, in finance from Florida State University, and an M.B.A. from Kelley School of Business, Indiana University. Mr. Jones is a CFA charterholder. | ||
| John R. Schroer | Portfolio Manager | 2014 | 2018 |
| Biografia | Mr. Schroer, CFA, is a portfolio manager and a director with Allianz Global Investors, which he joined in 2014. He is the sector head of the Health Care team. He was previously the president of Schroer Capital, L.P.; an equity analyst with HealthCor Management, L.P.; a managing member and portfolio manager for ITROS Capital Management, LLC; a global partner, senior vice president, and portfolio manager for INVESCO; and an analyst for Trust Company of the West. Mr. Schroer has a B.S. in history and international relations and an M.B.A. in finance from the University of Wisconsin. | ||
| Michael Dauchot | Portfolio Manager | 2005 | 2018 |
| Biografia | Dr. Dauchot, CFA, is a portfolio manager, a senior research analyst and a director with Allianz Global Investors, which he joined in 1999. He is a member of the Health Care team, focusing on medical technology, life-science tools and diagnostics. He previously worked at Pequot Capital Management and BancBoston Robertson Stephens. Dr. Dauchot has a degree in chemistry from Case Western Reserve University, an M.B.A. from the Kellogg School of Management at Northwestern University and an M.D. from the University of Cincinnati College of Medicine. | ||
| Paul A. Wagner | Senior Research Analyst | 2008 | 2014 |
| Biografia | Mr. Wagner, CFA, is a portfolio manager, a senior research analyst and a director with Allianz Global Investors, which he joined in 2006. He has biotechnology responsibilities for the US Health Care team and has 14 years of investment-industry experience. Mr. Wagner previously worked at PDL BioPharma in corporate and business development, and was a vice president and senior equity-research analyst in the biotechnology sector at Lehman Brothers. He has a B.S. in chemistry from the University of Wisconsin and a Ph.D. in chemistry from the California Institute of Technology. | ||
| Ken H. Tsuboi | Health Care team | 2007 | 2013 |
| Biografia | Ken joined RCM in 1996, beginning his work on the Health Care team in 2000. Ken covers international healthcare companies, analyzing stocks for recommendation to the international portfolio management team. Previously, Mr. Tsuboi was an Asset Backed Analyst for RCM's fixed income team, where he was responsible for the implementation, strategy and evaluation of all asset- backed products. Prior to RCM, Ken was a Senior Portfolio Strategist at Payden & Rygel. | ||
| Dan Hunt | Member | 2008 | 2013 |
| Biografia | Dan was responsible for proprietary and client-directed investment idea generation across sectors, with an emphasis on healthcare. He was appointed (as the youngest member) to SG Cowen’s seven-person Investment Policy Committee. Prior to joining SG Cowen, Dan worked for Thomson Financial/Carson in New York as a Senior Associate within Capital Markets Intelligence. Dan holds the Chartered Financial Analyst designation. | ||
Escreva o que você pensa sobre Virtus Kar Health Sciences Fund Class A
Tem certeza que deseja excluir esse gráfico?
Apagar Cancelar
Substituir o gráfico anexado por um novo gráfico?
Substituir Cancelar
Diretrizes para Comentários
Anexar um gráfico a um comentário
Confirmar bloqueio
Tem certeza de que deseja bloquear %USER_NAME%?
Ao confirmar o bloqueio, você e %USER_NAME% não poderão ver o que cada um de vocês posta no Investing.com.
%USER_NAME% foi adicionado com êxito à sua Lista de bloqueios
Já que acabou de desbloquear esta pessoa, você deve aguardar 48 horas antes de bloqueá-la novamente.
Denunciar esse comentário
Diga-nos o que achou desse comentário
Comentário denunciado
Obrigado!
Seu comentário foi enviado aos moderadores para revisão